Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, ...

Speaking at Jamaica Stock Exchange’s 20th Regional Investments & Capital Markets Conference 2025, Fisher likened the current AI-driven market rally to past speculative bubbles, warning of potential ...

Brokerages Citi and Jefferies maintain "Buy" ratings on Indus Towers, Nippon Life India Asset Management, and UltraTech Cement, citing strong growth potential, cost efficiencies, and improved ...

Dr Reddy’s share prices dropped today as brokerages cut targets due to weak US and India performance. Explore the financial outlook now!

Jefferies ’ global head of its private capital group Matthew Wesley is departing the investment bank to join Moelis & Co. Wesley is set to take over as head of private funds advisory at Moelis, six ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.82% of ...

The carrier predicted that it would generate an adjusted per-share loss of 20 cents to 40 cents for the current quarter, driven by relatively weak demand and high fuel prices.

Top Canadian pension fund Ontario Teachers' Pension Plan Board ( OTPP) has engaged investment bank Jefferies as an advisor ...

Citi led in deal value with advisories worth $60.8bn, while Jefferies dominated in deal volume, advising on 23 transactions.

Jefferies has downgraded Dentsply Sirona (NASDAQ:XRAY) to hold from buy, citing ongoing macro headwinds and company-specific issues. The investment bank noted that macro issues have negatively ...

In a report released today, Alexander Slagle from Jefferies maintained a Buy rating on Performance Food Group (PFGC – Research Report), with a ...

This collaboration has helped us to make more informed decisions and stay competitive in an evolving landscape,” said Angela Lobo, head of eSales and sales chief operating officer, Jefferies.